RECRUITINGINTERVENTIONAL

Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients

Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients: Randomised Clinical Trial

About This Trial

Study in which a zinc oxide fixation device (a product that can help protect the skin) for catheters (polyurethane tubes inserted into a vein) will be tested to reduce catheter-related complications: catheter displacement, skin complications, phlebitis and pain..

Who May Be Eligible (Plain English)

Who May Qualify: - requiring cannulation of a midline catheter or a PICC - who accepted and signed the willing to sign a consent form voluntarily - with an inpatient unit admission of minimum 7 days Who Should NOT Join This Trial: \- patients with a known allergy to zinc oxide Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * requiring cannulation of a midline catheter or a PICC * who accepted and signed the informed consent voluntarily * with an inpatient unit admission of minimum 7 days Exclusion Criteria: \- patients with a known allergy to zinc oxide

Treatments Being Tested

PROCEDURE

Control group: acrylic adhesive sutureless fixation device

The standard care consists of: * Application of hemostasis at the point of insertion for 2 minutes post puncture or until bleeding stops. * Fix with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and acrylic adhesive sutureless fixation device (3300MWA Grip-Lok®).

PROCEDURE

Intervention Group: zinc oxide sutureless fixation device

Alternative care consisted of: * Application of haemostasis at the insertion site for 2 minutes post-puncture or until cessation of bleeding. * Fixation with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and zinc oxide sutureless fixation device (2200NUZA Grip-Lok®).

DEVICE

PICC

The PICC lines used in the study will all be third-generation polyurethane and of the commercial brands: * PowerPICC™ 4, 5 and 6 Fr from BD * Maxflo expert™ 5 and 6 Fr from Vygon

DEVICE

Midline

The midline lines used in the study will be second or third generation polyurethane and of the commercial brands: * PowerMidline™ 4 Fr from BD * Arrow® Midline 4Fr from Arrow

OTHER

Ultrasound scanner

All punctures will be performed under ultrasound guidance.

Locations (2)

Arnau de Vilanova Hospital

Lleida, Catalonia, Spain

Hospital Universitari Arnau de Vilanova

Lleida, Catalonia, Spain